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Background/aim: Juvenile obesity is associated with several metabolic abnormalities, one of them being atherogenic dyslipidemia.
Suboptimal fetal growth is associated with obesity risk in childhood, but also with increased rate of metabolic diseases in later life. This
study investigated associations of neonatal data (Apgar score, birth weight and birth length) with low-density lipoprotein and highdensity lipoprotein (LDL and HDL) subclasses in a group of obese children, as well as a possible impact of breastfeeding duration on
obesity-associated lipoprotein subclasses distributions.
Materials and methods: We included 42 obese children, aged 14.2 ± 2.1 years. LDL and HDL subfractions were separated by gradient
gel electrophoresis and biochemical parameters were assessed by routine methods.
Results: Compared with obese children with Apgar ≥ 9, the group with Apgar < 9 had significantly higher percentages of small, dense
LDL particles (P < 0.05), due to reduced LDL I (P < 0.01) and increased LDL III subclasses (P < 0.05). Birth weight was positively
associated with the proportions of LDL I particles (P < 0.001), whereas birth height positively correlated with the amount of HDL 2b
subclasses (P < 0.05). The group of never or less than 3 months breastfed children had significantly smaller LDL size (P < 0.01) and lower
proportion of HDL 2a particles (P < 0.05) than their ≥3 months breastfed peers.
Conclusion: The results showed significant associations of neonatal characteristics with LDL and HDL particle distributions in obese
children. In addition, our results point toward positive aspects of longer breastfeeding duration on lipoprotein particle distributions in
obese children.
Key words: Childhood obesity, small dense LDL, HDL subclasses, Apgar, breastfeeding

1. Introduction
The growing trend of childhood obesity represents a major
health concern worldwide (1). It is now well documented
that obesity is linked to increased cardiovascular
disease (CVD) risk in adults (2). However, even if CVD
complications usually become manifested in adulthood,
the process of atherogenesis might start much earlier.
To date, a body of evidence has been gathered implying
that atherosclerosis may begin in childhood (3). Taken all
together, childhood obesity seems to be significant risk
factor for the onset of CVD (4).
Although there is no doubt that any strategy for
prevention of atherosclerosis should include children and
adolescents, there is no consensus regarding independent
association of childhood obesity with CVD risk factors
in later life (5). However, it has been demonstrated that
* Correspondence: alex@pharmacy.bg.ac.rs
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overweight and obese children have a greater likelihood
of developing hypertension and type-2 diabetes, as well as
ischemic heart and brain diseases (6). In general, obesity
is associated with numerous metabolic abnormalities
(3), which may magnify cardiovascular risk. Excessive
adipose tissue accumulation results in the release of
several adipokines that contribute to the pathogenesis
of inflammation and hypertension (7). Apart from
inflammation, abnormalities in serum lipid levels are
also typically seen in obesity. Although increased lowdensity lipoprotein (LDL)-cholesterol (LDL-C) and low
high-density lipoprotein (HDL)-cholesterol (HDL-C)
concentrations are well-known as major atherosclerosis
risk factors, it is now recognized that certain lipoprotein
subclasses, particularly small, dense LDL and HDL,
may further distinguish an individual’s CVD risk (8). In
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accordance, atherogenic dyslipidemia has emerged as an
increasingly prevalent risk factor in children, concomitant
with obesity (9).
It is well known that predisposition to obesity is
determined by genetic and environmental risk factors.
On the other hand, the concept that fetal life is a critical
time for lifelong cardiovascular consequences is also
well supported (10). According to the available evidence,
gestational obesity is able to predispose the offspring to the
development of CVD in adulthood (11). We have recently
demonstrated that higher proportions of small, dense
LDL particles in maternal plasma before delivery were
independently associated with smaller weight and length
of newborns (12). A low size at birth, related to suboptimal
fetal environment, has been associated with obesity risk in
childhood (13) but also with increased rate of metabolic
diseases in later life (14). In addition, Apgar score, an
indicator of a newborn’s vitality, can also offer additional
prognostic information on future morbidity and mortality
(15). So far, there have been no studies on the association
between neonatal data and lipoprotein subclasses profile
in obese children.
Another important aspect related to further
cardiovascular health of the child is dietary pattern
during the early postnatal period. Nowadays, exclusive
breastfeeding is considered the optimal source of nutrition
in early life (16). Moreover, breastfeeding has been found
to be protective against development of atherosclerosis in
terms of reducing CVD risk factors (17). In the reviewed
literature, there is no study investigating the impact of
breastfeeding on lipoprotein subclasses distribution in
obese children.
In this study we aimed to evaluate possible
associations of neonatal data (Apgar score, birth weight,
and birth length) with LDL and HDL subclasses in
a group of obese children. In addition, we examined
whether breastfeeding duration had an impact on obesityassociated lipoprotein subclass distributions.
2. Materials and methods
2.1. Patients
The study included obese children who attended medical
check-ups at the University Children’s Hospital. The
inclusion criteria were absence of secondary hypertension
and obesity associated with any medical conditions, as
well as use of any medication. As a result, a total group
of 42 subjects, aged 10–18 years, who had completed all
required data and measurements were included in the
study. Neonatal data were gathered from medical records
and included Apgar score, birth weight, and birth height.
Breastfeeding was considered as any kind of breastfeeding,
i.e. exclusive and partial breastfeeding. Duration of
breastfeeding was self-reported by parents.

The study was executed following the ethical guidelines
of the Declaration of Helsinki. The study protocol was
approved by the institutional review committee. All
patients and their parents were completely informed and
gave written consent for participation.
2.2. Anthropometric measurements
Each patient’s weight, height, waist, and hip circumferences
were measured. Body-mass index (BMI) and BMI z-score
values were calculated according to a previously proposed
model (18). Childhood obesity was considered if BMI was
≥95th percentile.
2.3. Laboratory analyses
Blood samples were collected into evacuated tubes
containing EDTA and serum sample tubes after a 12-h
fasting period. Plasma and serum were separated by
immediate centrifugation at 1500 × g for 10 min at 4 °C.
Aliquots of each sample were stored at −80 °C and thawed
immediately before analyses.
Concentrations of glucose, total cholesterol (TC),
triglycerides (TG), LDL-C, and HDL-C were measured
by routine laboratory methods (Olympus Diagnostica
GmbH, Hamburg, Germany). LDL and HDL subclasses
were measured by the modified method of Rainwater et al.
(19), as previously published in detail (20). We determined
migration distances for absorbance peaks and used them
for assessment of the particle diameter. Diameters of the
most prominent peaks in the LDL and HDL regions of each
scan were labelled as dominant particle sizes. The areas
under the peaks corresponding to each LDL and HDL
subclass were also determined and referred to as relative
proportions of particular subfractions. The proportion
of small, dense LDL was also ascertained as the area at
or below 25.5 nm in the densitometric scan. Likewise,
percentage of small, dense HDL particles was determined
as the area of the densitometric scan at or below 8.8 nm
(20). Increased small, dense LDL particle proportion was
considered if the absorbance in the region corresponding
to LDL size ≤ 25.5 nm was higher than 50% (19). All assays
were performed blindly.
2.4. Statistical analysis
Normally distributed continuous variables were shown
as mean ± standard deviation (SD). Variables that did
not fit into normal distribution were presented as median
(interquartile range), and categorical variables as relative
or absolute frequencies. Group differences were analyzed
by Student’s t-test (if the data were normally distributed)
or by Mann–Whitney test (if the data were asymmetrical).
Categorical data were analyzed by chi-square test. We
employed Spearman’s correlation analysis for assessment
of significant associations. Minimal statistical significance
was set at P < 0.05 and the statistical software MedCalc for
Windows version 9.6.3. (Mariakerke, Belgium) was used
for analysis.
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3. Results
Table 1 represents the demographic and laboratory data
of 42 obese children. The study participants were 14.2 ±
2.1 years old and 37 of them (88.1%) were pubertal. All
children had BMI above the 95th percentile and were
characterized by central obesity, as indicated by high waistto-hip ratios (range: 0.82–1.04). Regarding neonatal data,
all children were born at term. Normal birth weight had
35 (83.3%) participants, 6 (14.3%) had high birth weight
(>4000 g), and one child had low birth weight (<2500 g).
According to Apgar rating, 10 infants (23.8%) had a score
less than 9, including three subjects with a score less than
7. Data on breastfeeding were available for 40 children.
Among them, 85% were breastfed for at least 1 month
(median: 7.5 months).
The study participants were initially classified
according to the Apgar score (Table 2). The two groups
were homogeneous in terms of age and sex. Obese
children with Apgar < 9 had significantly lower birth
weight than the group with Apgar ≥ 9. On the other hand,
anthropometric variables (weight, BMI, waist and hip
circumferences) in childhood did not differ between the
groups. Similarly, no differences in lipid status parameters
were detected. Compared with the children with Apgar ≥
9, the group with Apgar < 9 showed a tendency toward
smaller LDL and HDL particles sizes (P = 0.098 and P =
0.087, respectively). Furthermore, the children with Apgar
< 9 had significantly increased proportion of LDL III (P <
0.05) with parallel reduction in LDL I subclasses (P < 0.01)
than those with Apgar ≥ 9. As a result, the proportion
of small, dense LDL particles was significantly higher in
the children with Apgar < 9 (P < 0.05). HDL subclasses
distribution did not differ between the groups.
Next, we performed Spearman’s correlation analysis
(Table 3) and found that Apgar score was in positive
correlation with LDL size and relative proportions of LDL
I subclasses, and in inverse correlation with the percentage
of small, dense LDL particles. Moreover, Apgar score was
positively associated with the proportions of HDL 3a
subclasses.
With regard to the previous findings, we additionally
analyzed potential associations of lipoprotein heterogeneity
with birth size (Table 3). We found that birth weight was
positively related to the proportions of LDL I and inversely
associated with the proportions of HDL 3c subclasses
(Table 3). No significant correlations were found between
birth height and LDL subclasses. On the other hand, HDL
size and relative proportions of HDL 2b particles were
positively associated, while the proportions of HDL 3c
were in negative correlation with birth height.
In further analysis, we examined the impact of
breastfeeding on clinical and laboratory parameters in
childhood (Table 4). Eight children did not breastfeed at
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Table 1. Clinical and laboratory parameters of study participants.
Obese children
(n = 42)
Age, years

14.2 ± 2.1

Sex, boys/girls

30/12

Prepubertal/pubertal

5/37

Apgar score

8.7 ± 1.3

Birth weight, g

3392.6 ± 587.4

Birth length, cm

52.4 ± 3.5

Breastfeeding, %

85

Breastfeeding duration, months #

7.5 ± 3.13

Weight, kg

88 ± 20.0

Height, m

170 ± 12.8

BMI, kg/m2

30.2 ± 3.9

BMI percentile

97.2 ± 1.2

BMI z-score

3.14 ± 0.99

Waist circumference, cm

97 ± 9.4

Hip circumference, cm

103 ± 11.9

Waist-to-hip ratio

0.94 ± 0.06

Glucose, mmol/L

4.79 ± 0.57

TC, mmol/L

4.25 ± 1.14

LDL-C, mmol/L

2.74 ± 1.16

HDL-C, mmol/L

1.06 ± 0.24

TG, mmol/L #

0.88 (0.69–1.22)

LDL size, nm

27 ± 1.29

LDL I, %

21 ± 6.7

LDL II, %

24 ± 4.0

LDL III, %

20 ± 4.6

LDL IV, %

35 ± 8.4

Small, dense LDL, %

55 ± 9.4

HDL size, nm

9 ± 1.17

HDL 2b, %

40 ± 7.9

HDL 2a, %

19 ± 4.9

HDL 3a, %

15 ± 2.8

HDL 3b, %

9 ± 3.3

HDL 3c, %

17 ± 7.5

Small, dense HDL, %

41 ± 9.9

Data are presented as mean ± SD, and absolute or relative
frequencies for categorical variables
#
Data are presented as median (IQR).
BMI, body-mass index; TC, total cholesterol; LDL, low-density
lipoprotein; LDL-C, low-density lipoprotein cholesterol ; HDL,
high-density lipoprotein; HDL-C, high-density lipoprotein
cholesterol; TG, triglycerides.
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Table 2. Clinical and laboratory parameters according to Apgar score.

Age, years

Apgar < 9
(n = 10)

Apgar ≥ 9
(n = 9)

P

14.7 ± 2.1

14.1 ± 2.2

0.369

Sex, boys/girls

9/1

20/11

0.231

Apgar score

7.0 ± 1.5

9.3 ± 0.5

<0.001

Birth weight, g

2944 ± 667.4

3523 ± 496.5

<0.05

Birth length, cm

50 ± 4.5

53 ± 2.8

0.085

Weight, kg

96 ± 25.5

85 ± 17.8

0.149

Height, m

175 ± 12.8

168 ± 12.4

0.136

BMI, kg/m2

30.7 ± 5.4

30.0 ± 3.4

0.652

BMI z-score

3.22 ± 1.52

3.12 ± 0.81

0.807

Waist circumference, cm

98 ± 12.3

97 ± 8.5

0.870

Hip circumference, cm

106 ± 17.6

103 ± 9.7

0.383

Waist-to-hip ratio

0.93 ± 0.07

0.95 ± 0.05

0.286

Glucose, mmol/L

4.65 ± 0.49

4.85 ± 0.59

0.349

TC, mmol/L

4.09 ± 0.69

4.33 ± 1.26

0.582

LDL-C, mmol/L

2.53 ± 0.52

2.84 ± 1.31

0.476

HDL-C, mmol/L

1.04 ± 0.22

1.07 ± 0.25

0.731

TG, mmol/L

1.02 (0.64–1.20)

0.86 (0.70–1.23)

0.870

LDL size, nm

26 ± 1.4

27 ± 1.2

0.098

LDL I, %

17 ± 3.1

22 ± 7.3

<0.01

LDL II, %

23 ± 3.8

25 ± 4.1

0.207

LDL III, %

22 ± 2.1

19 ± 4.9

<0.05

LDL IV, %

38 ± 7.2

34 ± 8.7

0.190

Small, dense LDL, %

60 ± 6.3

53 ± 9.9

<0.05

#

HDL size, nm

9 ± 0.8

10 ± 1.2

0.087

HDL 2b, %

41 ± 7.4

40 ± 8.1

0.770

HDL 2a, %

20 ± 6.6

18 ± 4.1

0.248

HDL 3a, %

14 ± 2.3

15 ± 2.9

0.146

HDL 3b, %

8 ± 3.3

10 ± 3.2

0.207

HDL 3c, %

17 ± 9.2

17 ± 6.8

0.970

Small, dense HDL, %

39 ± 10.2

42 ± 9.7

0.421

Data are presented as mean ± standard deviation, and absolute or relative frequencies for categorical
variables. Continuous variables were analyzed by Student’s t-test. Categorical variables were analyzed
by chi-square test.
#
- Data are presented as median (IQR) and analyzed by Mann–Whitney U test.
BMI, body-mass index; TC, total cholesterol; LDL, low-density lipoprotein; LDL-C, low-density
lipoprotein cholesterol ; HDL, high-density lipoprotein; HDL-C, high-density lipoprotein cholesterol;
TG, triglycerides.

all, while seven children were breastfed for 1 or 2 months
solely. On the other hand, 19 children were breastfed
≥ 6 months (min. 6 months; max. 24 months) and six
children were breastfed 3, 4, or 5 months. Due to unequal
distribution of children, the study participants were

classified according to breastfeeding duration into the
group of never or less than 3 months breastfed children
and the group of children who were breastfed for 3 months
or more. The newly formed groups were even in term of
age and sex. Analysis of neonatal data showed that children
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Table 3. Correlations of lipoprotein subclasses with Apgar score, birth weight, and birth height.
Lipoprotein subclasses

Apgar score

Birth weight, g

Birth height, cm

LDL size, nm

0.365 *

0.161

0.146

LDL I, %

0.386 *

0.517 **

0.164

LDL II, %

0.172

0.173

–0.013

LDL III, %

–0.238

–0.186

–0.115

LDL IV, %

–0.271

–0.020

–0.020

Small, dense LDL, %

–0.306 *

–0.047

–0.047

HDL size, nm

0.248

0.224

0.350 *

HDL 2b, %

0.002

0.165

0.357 *

HDL 2a, %

–0.036

0.057

–0.033

HDL 3a, %

0.363 *

0.260

–0.002

HDL 3b, %

0.175

0.115

–0.157

HDL 3c, %

–0.182

–0.348 *

–0.322 *

Small, dense HDL, %

–0.009

–0.139

–0.267

** P < 0.001; * P < 0.05

in the group breastfed ≥ 3 months had significantly higher
Apgar score than those who were not breastfed at all or
were breastfed for less than 3 months. Anthropometric
variables did not differ between the two groups. Even if we
did not find differences in lipid status parameters, further
insight into the characteristics of lipoprotein particles
showed that the group of never or less than 3 months
breastfed children had significantly smaller LDL size (P
< 0.01) and reduced proportion of HDL 2a particles (P <
0.05) than their ≥3 months breastfed peers.
4. Discussion
Over the past decades the prevalence of obesity among
children and adolescent has considerably increased
(1). Hence, in view of the growing trends of childhood
obesity, primary prevention in youths seems to be the
main approach to combat the development of numerous
metabolic consequences, particularly CVD (6). Although
the concept of obesity-related dyslipidemia is well
understood in adults, quantitative evaluation in pediatric
population is more complex. Namely, even if serum lipid
parameters in obese children and adults have similar
levels, in terms of higher TG and reduced HDL-C,
younger populations usually have desirable or slightly
elevated LDL-C concentrations (21). In line with previous
research, obese children in the current study showed no
dramatic abnormalities in serum lipid parameters (Table
1). However, our more in-depth analysis of lipid status
revealed high proportions of small, dense LDL and HDL
particles (Table 1), in spite of relatively optimal serum
lipid parameters. Recently, LDL and HDL subclasses
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characteristics in a group of healthy children of the same
origin were published by Zeljkovic et al. (22). Both small,
dense LDL and HDL particles in the current study of obese
children were higher when compared to the data from
healthy children in the study by Zeljkovic et al. (22). A
prevalence of small, dense LDL particles in obese children
has been previously reported, although the results were not
entirely consistent (9). In contrast, a relationship of small
HDL particles with childhood obesity has been firmly
established (23). To date, numerous studies provided solid
evidence that small, dense LDL particles have the greatest
atherogenic potential, due to easier penetration into
arterial intima, longer retention in subendothelium, and
higher oxidative susceptibility (8). It is well known that
high HDL-cholesterol levels are associated with decreased
cardiovascular risk. By reverse cholesterol transport
HDL particles accept cholesterol from the periphery,
such as arterial wall cells, and deliver it to the liver.
Reverse cholesterol transport is the major mechanism
of antiatherogenic effects of HDL (24). In addition, a
hypothesis that smaller HDL particles have diminished
anti-atherogenic capacity in the conditions associated
with dyslipidemia, inflammation, and enhanced oxidative
stress was also confirmed (24). Therefore, a finding of proatherogenic small, dense LDL and HDL particles in obese
children could indicate higher cardiovascular risk than
anticipated by standard lipid measurement.
So far, numerous risk factors in children have been
evaluated in terms of possible association with increased
CVD risk in later life. Recently reviewed data suggest that
cardiovascular risk in adulthood is more likely associated

BEKHET et al. / Turk J Med Sci
Table 4. Clinical and laboratory parameters according to breastfeeding duration.
Breastfeeding
<3 months and
none (n = 15)

≥3 months
(n = 25)

P

Age, years

14.0 ± 2.1

14.4 ± 2.2

0.573

Sex, boys/girls

10/5

19/6

0.716

Apgar score

8.2 ± 1.7

9.0 ± 0.9

<0.05

Birth weight, g

3256 ± 638.5

3456 ± 571.9

0.312

Birth length, cm

52 ± 4.5

52 ± 2.7

0.653

0 (0–1)

12 (5–13.5)

<0.001

Weight, kg

87.1 ± 20.6

88.8 ± 20.6

0.801

Height, m

167 ± 12.6

171 ± 13.1

0.322

Breastfeeding duration, months

#

BMI, kg/m

30.7 ± 4.1

29.9 ± 3.9

0.545

BMI z-score

3.32 ± 0.95

3.06 ± 1.06

0.427

Waist circumference, cm

97 ± 10.7

97 ± 8.9

0.987

Hip circumference, cm

103 ± 12.7

104 ± 11.9

0.764

Waist-to-hip ratio

0.95 ± 0.06

0.94 ± 0.06

0.608

Glucose, mmol/L

4.65 ± 0.52

4.84 ± 0.56

0.294

TC, mmol/L

4.15 ± 1.64

4.38 ± 0.76

0.546

LDL-C, mmol/L

2.82 ± 1.67

2.76 ± 0.78

0.612

HDL-C, mmol/L

1.09 ± 0.24

1.04 ± 0.25

0.868

TG, mmol/L

2

0.83 (0.60–1.10)

1.02 (0.78–1.27)

0.125

LDL size, nm

26 ± 1.19

27 ± 1.32

<0.01

LDL I, %

19 ± 4.4

22 ± 7.9

0.176

LDL II, %

25 ± 3.1

24 ± 4.6

0.404

LDL III, %

20 ± 4.6

20 ± 4.6

0.887

LDL IV, %

36 ± 6.2

34 ± 9.8

0.529

Small, dense LDL, %

56 ± 6.9

54 ± 11.0

0.621

HDL size, nm

9 ± 1.36

9 ± 1.09

0.845

HDL 2b, %

41 ± 7.6

40± 8.3

0.684

HDL 2a, %

17 ± 5.0

20 ± 4.1

<0.05

HDL 3a, %

14 ± 3.1

15 ± 2.7

0.304

HDL 3b, %

10 ± 3.8

9 ± 2.9

0.443

HDL 3c, %

18 ± 8.2

16 ± 6.8

0.341

Small, dense HDL, %

42 ± 10.9

40 ± 9.3

0.502

#

Data are presented as mean ± standard deviation, and absolute or relative frequencies for categorical variables.
Continuous variables were analyzed by Student’s t-test. Categorical variables were analyzed by chi-square test.
#
- Data are presented as median (IQR) and analyzed by Mann–Whitney U test.
BMI, body-mass index; TC, total cholesterol; LDL, low-density lipoprotein; LDL-C, low-density lipoprotein
cholesterol ; HDL, high-density lipoprotein; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides.

with tracking of overweight and dietary habits while
growing up, rather than with obesity in childhood (5).
On the other hand, prospective data indicate an inverse
association of smaller neonatal body size with the onset

of CVD in adulthood (25). In recent years, great attention
has been paid to analyzing the link between different
biomarkers in maternal plasma and smaller birth size,
as well as their consequences on further morbidity
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and mortality risk of infants. In our previous study, we
demonstrated independent associations between smaller
LDL and HDL particles in maternal plasma before
delivery and lower newborn’s size (12), indicating that
adverse lipoprotein subclasses profile in pregnancy affects
fetal growth. The current study extends our previous
observation, showing that size at birth might be associated
with lipoprotein subclasses distribution in childhood. Our
finding of inverse associations of birth weight and length
with relative proportions of the largest LDL and HDL
particles (Table 3) suggests that regular fetal growth may
have a positive influence on lipid profile in childhood,
even in the presence of juvenile obesity. According to the
“fetal programming” concept, a growth restriction in utero
has an important impact on CVD risk in adulthood. The
hypothesis has been supported by an inverse association
between birth weight and subsequent blood cholesterol
concentration (26), although some authors dispute this
theory (27). In our obese children, both smaller birth length
and height were related to increased proportion of small,
dense HDL particles (Table 3). It has been established that
obesity is associated not only with increased prevalence of
small, dense HDL particles, but also with changes in their
composition, which further affects their functionality (28).
Bearing in mind that these particles have compromised
atheroprotective potential (24), the observed inverse
association of smaller birth size and increased smaller
HDL could be another piece of the puzzle linking restricted
fetal growth with future cardiovascular complications. It
should also be stressed that, following systematic analysis
of available data, Huxley et al. (27) concluded that the
effect of impaired fetal growth on cholesterol level,
and consequently on CVD risk, should be considered
marginal. This is not surprising giving the fact that plasma
cholesterol concentration per se has low predictive value
for CVD. Moreover, this conclusion further supports the
concept of advanced lipoprotein testing for cardiovascular
prevention (29), starting from infancy onward.
Besides newborn size, optimal fetal environment is
reflected by Apgar score. A lower Apgar score at birth is
an indicator of poorer vitality of the newborn and it has
been connected to later developmental disorders and risk
of cancer (15). Yet, a link between Apgar score and CVD
risk factors in childhood has not been investigated so far.
According to our results, childhood obesity is unrelated to
Apgar score, since the majority of the study participants
had desirable Apgar values (Table 2). However, in our obese
children lower Apgar score was also associated with lower
birth weight (Table 2), suggesting that this specific scenario
might further affect CVD risk. Indeed, this group of obese
children was characterized by significant redistribution
of LDL subclasses towards small, dense particles (Table
2). A possible explanation of our results could lie in the

1810

fact that our obese children with lower Apgar score have
comparable present values of anthropometric variables as
their higher Apgar score counterparts (Table 2), suggesting
that these children experienced accelerated growth. It has
been demonstrated that rapid growth during infancy is
associated with longer-term problems of obesity (30).
Hence, subsequent accelerated weight gain could also be
responsible for the observed accumulation of small, dense
LDL particles in the group with Apgar < 9. Additionally,
our for-the-first time documented inverse association
between Apgar score and small, dense LDL particles
(Table 3) forms the basis for exploring this link in future
investigations.
Nutrition in infancy seems to have important effect on
both weight gain and lipoprotein metabolism. There is a
consensus that breast milk and prolonged breastfeeding
prevent long-term overweight and obesity (31). To the
best of our knowledge, this study is the first to describe an
impact of breastfeeding duration on lipoprotein subclasses
distribution in obese children. Our analysis showed that
never or less than 3 months breastfed children have smaller
LDL size and less HDL 2 particles than children who were
breastfed for 3 months or more (Table 4). The results of
the studies investigating the impact of breastfeeding
on serum lipid profile are inconclusive. Some authors
reported that breastfeeding duration was inversely
associated with LDL-C levels (32), while others found
no significant association (33). On the other hand, use of
nutrient enriched formula, as an alternative or supplement
to breastfeeding, was associated with alteration in serum
lipid profile of infants (34). In addition, Ravelli et al.
(35) reported that adults who were exclusively breastfed
had lower LDL-C and apolipoprotein B, as well as lower
LDL/HDL ratio than their formula-fed peers. Our present
findings extend previous observations (35) and provide
additional evidence that consumption of breast milk is an
important strategy to prevent CVD development from a
young age.
In conclusion, the results of the current study have
shown significant associations of neonatal characteristics
with LDL and HDL particle distributions in obese children.
In particular, we have demonstrated that lower Apgar
score (<9) and smaller newborn’s size are associated with
pro-atherogenic LDL and HDL particles in childhood.
In addition, our results point toward positive aspects of
longer breastfeeding duration on lipoprotein particle
distributions in obese children.
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